AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 151 min read$COO

Rosebrough Walter M Jr purchased $542K of COO (indirect holdings)

Rosebrough Walter M Jr purchased 10,000 indirectly-held shares of COOPER COMPANIES, INC. (COO) at an average of $54.16 ($54.11–$54.29, $0.54M total) across 2 trades over 2026-09-11 to 2026-09-14.

Original reporting
SEC EDGAR · Rosebrough Walter M Jr
Published Sep 15, 2026, 8:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$COO
Neutral
medium confidence
Mentioned
$COO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$COONeutralLow
01

Why it matters

The insider purchase adds a modest bullish signal but is unlikely to move the stock materially.

02

Market read

Primary source filing with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed may influence insider behavior.

Relevance 6/10Novelty 5/10Timing: immediately after Form 4 filing

Background

Cooper Companies (COO) is a medical device and health services firm.

Company-level read

Ticker impact

$COONeutralMedium confidence
Context

Director Walter M. Rosebrough Jr purchased 10,000 shares for $541,640, increasing his holding to 20,000 shares.

Expected impact

Minimal short-term price movement expected.

Evidence & confidence

Purchase size is modest relative to market cap; typical for 10b5-1 plans.

Market effects

Sector

None significant for the healthcare services sector.

Regional

No regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The purchase could be routine and not indicative of future performance.

Key entities

  • Director
    Walter M. Rosebrough Jr

    Insider who bought shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

COO insider trading history →

Related articles

SEP 21
$COOMedAI 8/10

A Failed Auction and a 15% Drop: Is Cooper Companies (COO) a Value Trap or a Bargain?

Cooper Companies (COO) ended its 9-month effort to sell CooperSurgical after bids undervalued the business, according to management. The stock dropped 15% to a 52-week low near $51 after a Q3 miss and cut outlook. The company's core contact lens business, CooperVision, posted flat organic revenue growth, contributing to the guidance cut. Management authorized a $1B share repurchase program, while Bank of America questioned the valuation. COO reported record Q3 free cash flow of $273M.

insidermonkey.com2 min
SEP 14
$COOMedAI 8/10

The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand

The Cooper Companies (COO) lowered its fiscal 2026 profit and revenue forecasts due to weaker-than-expected contact lens demand, with adjusted EPS now expected at $4.51–$4.55 and revenue at $4.23–$4.25 billion. Q3 revenue was $1.07 billion, missing estimates, though adjusted EPS beat at $1.15. The company cited U.S. channel inventory reductions as a key factor and decided to retain CooperSurgical.

finance.yahoo.com3 min
SEP 11
$COOMedAI 8/10

Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision

Cooper Companies (COO) reported Q3 FY2026 revenue of $1.066B, up 1%, and adjusted EPS of $1.15, up 4%. The company spent $339.1M on share buybacks and has $1.5B remaining in repurchase capacity. Fertility segment growth and strong cash flow offset weakness in CooperVision, which saw flat organic growth and revenue declines in Americas and Asia Pacific. Gross margin improved to 67% on a GAAP basis, while adjusted operating margin rose 30 basis points to 26%.

yahoo.com2 min
SEP 11
$COOMed

Why Cooper, Freeport-McMoRan, and Baker Hughes Plunged

Cooper Companies (COO) fell 14.67% after reporting Q3 revenue of $1.07B and Q4 guidance below estimates. Freeport-McMoRan (FCX) dropped 6.59% due to White House uncertainty on copper tariffs. Baker Hughes (BKR) declined 6.66% despite raising its full-year revenue guidance to $28.5B-$30.3B.

baystreet.ca2 min
SEP 11
$COOMedAI 8/10

COO Q2 Deep Dive: Inventory Actions and Strategic Review Shape Guidance

CooperCompanies reported Q2 revenue of $1.07B (flat YoY, 2.9% miss) and adjusted EPS of $1.15 (2.7% beat). Full-year guidance was lowered to $4.24B revenue and $4.53 EPS. The company reduced U.S. inventory and retained CooperSurgical after a strategic review. Management plans to invest in sales and R&D, aiming for future growth and improved margins.

yahoo.com2 min
SEP 10
$COOMedAI 8/10

Why is CooperCompanies Stock Down 15% Today?

CooperCompanies (COO) shares dropped 13.9% after Q3 earnings beat estimates but Q4 guidance fell short of expectations. The company also decided to retain CooperSurgical, removing a potential deal catalyst. U.S. distributor destocking is expected to continue impacting CooperVision's Q4 performance.

aol.com2 min